Trials / Completed
CompletedNCT00230347
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurgical ablation of liver tumors, in terms of radiographic response, will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stereotactic radiosurgery |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2007-01-01
- Completion
- 2007-02-01
- First posted
- 2005-09-30
- Last updated
- 2010-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00230347. Inclusion in this directory is not an endorsement.